FDA Investigator: Lawrence Harmon
- Lawrence Harmon first started conducting FDA inspections in 2001, with the last inspection in 2007. Over that time, Lawrence Harmon has conducted 17 inspections at 16 companies across 16 sites.
Get Lawrence Harmon's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 Eurofins Dr. Specht Laboratorien, GmbH, Hamburg | 2006
Out-of-stock
Lawrence Harmon
Human Drug Form 483
FDA 483 C.P.M. Contract Pharma GmbH & Co. KG, Feldkirchen-Westerham | 2006
Out-of-stock
Lawrence Harmon
Human Drug Form 483
FDA 483 K.A.B.S. Laboratories Inc., Saint-Hubert | 2005
Out-of-stock
Lawrence Harmon
Human Drug Form 483
FDA 483 Boehringer Ingelheim Chemicals Inc, Petersburg | 2004
Out-of-stock
Lawrence Harmon
Animal Drugs & Feed Form 483
FDA 483 Barr Laboratories, Inc. (div. Of Teva), Forest | 2004
Out-of-stock
Lawrence Harmon
Human Drug Form 483
FDA 483 Pharmaceutics International, Inc., Hunt Valley | 2002
Out-of-stock
Lawrence Harmon
Human Drug Form 483
Co-Investigators (15)
- William A. Warnick, FDA Investigator
- Karen K. Takahashi, FDA Investigator
- Simone E. Pitts, FDA Investigator
- Brooke K. Higgins, FDA Investigator
- Jose R. Hernandez, FDA Investigator
- Brian R. Yaun, FDA Investigator
- Douglas A. Campbell, FDA Investigator
- Melissa J. Garcia, FDA Investigator
- Kenneth Nieves, FDA Investigator
- Joseph W. Matthews, FDA Investigator
- Barbara A. Gullick, FDA Investigator
- Wanda Y. Honeyblue, FDA Investigator
- George Pyramides, FDA Investigator
- Russell J. Glapion, FDA Investigator
- Gifford Whitehurst, FDA Investigator